Skip to main content
. Author manuscript; available in PMC: 2010 Jun 15.
Published in final edited form as: Genes Chromosomes Cancer. 2009 May;48(5):419–428. doi: 10.1002/gcc.20651

TABLE 1.

Chromosomes Demonstrating Differential Aberration Rates in BRAF* or NRAS* Samples for Both Cell Lines and Tumors Include 4, 7 and 12.

Tumors
Cell Lines
Chrom. Mutation association Aberration type Mutant (n = 17) Wild type (n = 26) Mutant (n = 35) Wild type (n = 17) P-value (tumors;cell lines)
4 NRAS+ Loss 1.5 (3.9) 12.9 (22.8) 9.4 (28.3) 31.9 (37.1) 0.0120; 0.0359
12 NRAS+ Gain 0.8 (1.9) 7.1 (10.0) 0.5 (1.1) 6.0 (10.0) 0.0027; 0.0011
7 BRAF+ Gain 48.4 (35.3) 21.8 (34.2) 58.2 (37.9) 24.0 (38.0) 0.0199; 0.0172

Aberration rates were quantified by the proportion of the chromosome gained or lost. Standard deviations of these proportions appear in parentheses.